drugset / Trial / NCT02295774
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Single Centre, open label assignment phase II clinical study. To evaluate the effect of oral 200mg Methylene Blue tablets (administered 8x25mg) prior to endoscopy on double stranded DNA breaks in colonic biopsy samples assessed by histone gamma H2AX analysis, compared to control biopsies.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylene Blue | Diagnostic / imaging agent | 200 mg | Oral |